Drug intelligence / Profile preview

corticosteroid + bupivacaine

Development stage
Unknown
Lead developer
Montefiore Medical Center
Modality
Small Molecules
Administration
Percutaneous
01

Overview

Corticosteroid + bupivacaine is a combination drug intervention used in CT-guided perineural injections for the treatment of acute lumbar radiculopathy and intervertebral disc herniation. This combination consists of a corticosteroid, which acts as a steroidal anti-inflammatory agent by targeting glucocorticoid receptors to reduce local inflammation and nerve root irritation, and bupivacaine, a long-acting local anesthetic that provides a nerve block by inhibiting sodium channels. The treatment is typically administered directly around the affected spinal nerve root under CT imaging guidance. It is currently being evaluated in clinical trials sponsored by Montefiore Medical Center to compare its efficacy against standard medical management in patients with disabling pain from herniated discs.

Other names
corticosteroid plus bupivacainecorticosteroid and bupivacainecorticosteroid + bupivicaine
02

Targets

SCN5A (Sodium channel protein type 5 subunit alpha)GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)PXR (Pregnane X receptor)PR (Progesterone receptor)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on corticosteroid + bupivacaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on corticosteroid + bupivacaine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call